ALAB vs MCHP: stock comparison and AI forecast
Astera Labs, Inc. (ALAB) and Microchip Technology Inc (MCHP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALAB Astera Labs, Inc.
- Price
- $258.70 +32.8% · 6M
- Market Cap
- $44.88B
- P/E Ratio
- 147.0x
- Size
- large-cap
- AI Forecast
MCHP Microchip Technology Inc
- Price
- $76.11 -20.1% · 6M
- Market Cap
- $41.33B
- P/E Ratio
- 111.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ALAB and MCHP have similar market capitalizations ($44.88B and $41.33B).
- MCHP trades at 111.9 times trailing earnings, ALAB at 147.0 times.
- Over the last six months ALAB returned +32.8% and MCHP -20.1%.
- ALAB turns 30.7% of its revenue into net income, against 9.3% for MCHP.
- MCHP carries 1.23 times debt per unit of equity, against 0.12 times for ALAB.
- MCHP yields 2.38% in dividends; ALAB pays none.
- Both companies share the SEC industry classification Semiconductors & Related Devices.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALAB | MCHP |
|---|---|---|
| Market Cap | $44.88B | $41.33B |
| P/E Ratio | 146.98x | 111.93x |
| P/B Ratio | 26.01x | 6.41x |
| Dividend Yield | – | 2.38% |
| EPS | $1.76 | $0.68 |
| Book Value/Share | $9.95 | $11.88 |
| Revenue/Share | $6.93 | $9.43 |
| FCF/Share | $1.59 | $2.05 |
Profitability & Margins
| Metric | ALAB | MCHP |
|---|---|---|
| ROE | 21.4% | 7.4% |
| ROA | 19.1% | 3.3% |
| ROIC | 15.5% | 6.1% |
| Gross Margin | 75.1% | 60.2% |
| Operating Margin | 22.8% | 15.5% |
| Net Margin | 30.7% | 9.3% |
| EBT Margin | 26.8% | 11.3% |
| Tax Rate | -14.7% | 17.4% |
Financial Health
| Metric | ALAB | MCHP |
|---|---|---|
| Current Ratio | 10.05x | 1.92x |
| Quick Ratio | 9.36x | 1.11x |
| D/E Ratio | 0.12x | 1.23x |
| Financial Leverage | 1.12x | 2.23x |
| Interest Coverage | – | 1.0x |
| Working Capital | $1.49B | $1.19B |
Cash Flow
| Metric | ALAB | MCHP |
|---|---|---|
| Operating Cash Flow | $336M | $1.20B |
| Free Cash Flow | $277M | $1.11B |
| Capital Spending | -$59M | -$87M |
| OCF Growth YoY | 34.8% | 50.4% |
| FCF Growth YoY | 31.5% | 53.1% |
| FCF/Sales | 23.0% | 21.7% |
| CapEx/Sales | 4.9% | 1.7% |
Operational Efficiency
| Metric | ALAB | MCHP |
|---|---|---|
| Asset Turnover | 0.62x | 0.36x |
| Receivables Turnover | 6.2x | 5.3x |
| Inventory Turnover | 2.6x | 1.9x |
| Fixed Assets Turnover | 10.1x | 4.7x |
| Days Sales Outstanding | 58 days | 69 days |
| Days Inventory | 139 days | 187 days |
| Payables Period | 66 days | 41 days |
| Cash Conversion Cycle | 132 days | 215 days |
Income Statement
| Metric | ALAB | MCHP |
|---|---|---|
| Total Revenue | $1.20B | $5.12B |
| Operating Income | $273M | $795M |
| Net Income | $369M | $478M |
| R&D Expense | $434M | $1.14B |
| SG&A Expense | $446M | $699M |
| Cost of Goods Sold | $299M | $2.04B |
Dividend & Shareholder Information
| Metric | ALAB | MCHP |
|---|---|---|
| Dividends Per Share | – | $1.81 |
| Payout Ratio | – | 266.2% |
| Shares Outstanding | 173M | 543M |
| Net Income Growth | 268.9% | – |
ALAB vs MCHP: stock comparison and AI forecast
Which is bigger, ALAB or MCHP?
ALAB and MCHP have similar market capitalizations ($44.88B and $41.33B).
Which is cheaper on earnings, ALAB or MCHP?
MCHP trades at 111.9 times trailing earnings, ALAB at 147.0 times.
Which stock performed better over the last six months, ALAB or MCHP?
Over the last six months ALAB returned +32.8% and MCHP -20.1%.
Which one does Intratio's AI model rank higher, ALAB or MCHP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.